NORGES BANK - EAGLE PHARMACEUTICALS INC ownership

EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 148 filers reported holding EAGLE PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 0.35 and the average weighting 0.9%.

Quarter-by-quarter ownership
NORGES BANK ownership history of EAGLE PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$350,760
+10.6%
12,0000.0%0.00%
Q3 2022$317,040
-91.1%
12,000
-85.9%
0.00%
-100.0%
Q1 2021$3,554,000
-55.7%
85,141
-50.5%
0.00%
-50.0%
Q4 2020$8,018,000
+2.9%
172,174
-6.1%
0.00%0.0%
Q3 2020$7,792,000
-25.8%
183,420
-16.2%
0.00%
-33.3%
Q2 2020$10,505,000
+2.1%
218,937
-2.1%
0.00%
-25.0%
Q1 2020$10,292,000
-31.0%
223,737
-9.8%
0.00%0.0%
Q4 2019$14,911,000
+6.2%
248,1790.0%0.00%0.0%
Q3 2019$14,039,000
+1.6%
248,1790.0%0.00%0.0%
Q2 2019$13,819,000
+10.3%
248,1790.0%0.00%0.0%
Q1 2019$12,531,000
+14.5%
248,179
-8.7%
0.00%0.0%
Q4 2018$10,948,000
-9.9%
271,747
+55.1%
0.00%0.0%
Q3 2018$12,146,000
+7.2%
175,201
+17.0%
0.00%0.0%
Q2 2018$11,335,000
+136.1%
149,808
+64.4%
0.00%
+100.0%
Q1 2018$4,801,000
-1.4%
91,1170.0%0.00%0.0%
Q4 2017$4,867,000
+12.2%
91,117
+25.3%
0.00%0.0%
Q3 2017$4,337,000
-59.9%
72,713
-47.0%
0.00%
-50.0%
Q2 2017$10,814,000
+12.8%
137,077
+18.6%
0.00%0.0%
Q1 2017$9,589,000
+70.2%
115,614
+62.8%
0.00%
+100.0%
Q4 2016$5,634,000
+18.7%
71,0080.0%0.00%0.0%
Q3 2016$4,747,00071,0080.00%
Other shareholders
EAGLE PHARMACEUTICALS INC shareholders Q1 2017
NameSharesValueWeighting ↓
Krensavage Asset Management, LLC 112,666$1,7770.65%
Smith, Graham & Co., Investment Advisors, LP 273,099$4,306,7710.54%
BRANDES INVESTMENT PARTNERS, LP 1,134,363$17,888,9040.35%
TANG CAPITAL MANAGEMENT LLC 118,857$1,874,3750.26%
Virtus Investment Advisers, Inc. 20,867$329,0730.22%
DENALI ADVISORS LLC 32,300$509,3710.18%
Nebula Research & Development LLC 11,473$180,9290.10%
SCOUT INVESTMENTS, INC. 131,192$1,995,4300.05%
XTX Topco Ltd 15,050$237,3390.04%
PDT Partners, LLC 19,745$311,3790.04%
View complete list of EAGLE PHARMACEUTICALS INC shareholders